December 12, 2019

Four Projects Funded That Will Pave the Way For Novel Anti-Cancer Therapies

Over $1 million awarded in funding focused on the development of novel therapeutics

The Mark Foundation for Cancer Research announced today that four research teams are the most recent ASPIRE Awards recipients.

The Mark Foundation is dedicated to accelerating cancer cures in part by facilitating the translation of laboratory research to the clinic.  In line with this philosophy, all four projects involve novel strategies for developing new anti-cancer therapies: a virus to shrink deadly brain tumors, a drug that targets the unique metabolism of tumors, a new class of drugs to stimulate the immune system, and fundamental research into the body’s stress response that could lead to therapeutic strategies to prevent metastasis.

Below are the projects funded, with links to full descriptions:

The ASPIRE (Accelerating Scientific Platforms and Innovative Research) program funds high risk, high reward approaches to solving complex problems in cancer research that tend to fall outside the scope of other funding opportunities. ASPIRE awards are designed to answer key proof-of-concept questions in a short timeframe.

For additional information about The Mark Foundation’s ASPIRE Awards, visit:

Back to all news